Cargando…
Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival
Sorafenib has been recommended as first- or second-line treatment for metastatic renal cell carcinoma (mRCC) by several guidelines. The objective of this study is to evaluate the efficacy of sorafenib monotherapy in Chinese patients with mRCC and determine the prognostic clinicopathologic factors as...
Autores principales: | Yu, Xiaoteng, Guo, Gang, Li, Xuesong, Zhang, Cuijian, Huang, Lihua, Fang, Dong, Song, Yi, Zhang, Xu, Zhou, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602909/ https://www.ncbi.nlm.nih.gov/pubmed/26313773 http://dx.doi.org/10.1097/MD.0000000000001361 |
Ejemplares similares
-
AB186. The efficacy and safety of sorafenib in Chinese patients with metastatic renal cell carcinoma and prognostic factors related to its efficacy
por: Yu, Xiaoteng, et al.
Publicado: (2015) -
The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
por: Tie, Xiaowei, et al.
Publicado: (2022) -
Prognostic impact of metastatic patterns and treatment modalities on overall survival in lung squamous cell carcinoma: A population-based study
por: Qin, Lang, et al.
Publicado: (2023) -
The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020) -
A Preoperative Nutritional Index for Predicting Cancer-Specific and Overall Survival in Chinese Patients With Laryngeal Cancer: A Retrospective Study
por: Fu, Yan, et al.
Publicado: (2016)